Devonian Health Group Inc (GSD) - Cash Flow Conversion Efficiency

Latest as of January 2026: -0.675x

Based on the latest financial reports, Devonian Health Group Inc (GSD) has a cash flow conversion efficiency ratio of -0.675x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-5.33 Million ≈ $-3.86 Million USD) by net assets (CA$7.90 Million ≈ $5.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GSD equity financing ratio to measure how much of total assets are equity-financed.

Devonian Health Group Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Devonian Health Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GSD cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Devonian Health Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Devonian Health Group Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SOLWERS OYJ EO 1 F:0ST	N/A
Stern Groep N.V. AS:PBH	0.907x
Canuc Resources Corp V:CDA	-0.866x
Dare Bioscience Inc NASDAQ:DARE	0.508x
Predictive Oncology Inc NASDAQ:POAI	0.021x
Sensei Biotherapeutics Inc NASDAQ:SNSE	-0.056x
Rocketdna Ltd AU:RKT	-0.192x
Ortivus AB ser. B ST:ORTI-B	-0.529x

Annual Cash Flow Conversion Efficiency for Devonian Health Group Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of Devonian Health Group Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Devonian Health Group Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$9.14 Million ≈ $6.61 Million	CA$-1.25 Million ≈ $-902.62K	-0.137x	-133.55%
2024-07-31	CA$13.86 Million ≈ $10.03 Million	CA$5.64 Million ≈ $4.08 Million	0.407x	+233.12%
2023-07-31	CA$14.25 Million ≈ $10.31 Million	CA$-4.36 Million ≈ $-3.15 Million	-0.306x	-73.26%
2022-07-31	CA$16.27 Million ≈ $11.77 Million	CA$-2.87 Million ≈ $-2.08 Million	-0.176x	+27.58%
2021-07-31	CA$7.52 Million ≈ $5.44 Million	CA$-1.83 Million ≈ $-1.33 Million	-0.244x	-12.78%
2020-07-31	CA$9.38 Million ≈ $6.79 Million	CA$-2.03 Million ≈ $-1.47 Million	-0.216x	-88.03%
2019-07-31	CA$10.08 Million ≈ $7.29 Million	CA$-1.16 Million ≈ $-837.62K	-0.115x	+31.72%
2018-07-31	CA$12.74 Million ≈ $9.21 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.168x	+43.31%
2017-07-31	CA$8.19 Million ≈ $5.92 Million	CA$-2.43 Million ≈ $-1.76 Million	-0.297x	+42.78%
2016-07-31	CA$4.13 Million ≈ $2.99 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.519x	-84.91%
2015-07-31	CA$5.19 Million ≈ $3.75 Million	CA$-1.46 Million ≈ $-1.05 Million	-0.281x	--

About Devonian Health Group Inc

V:GSD Canada Biotechnology

Market Cap

$18.61 Million

CA$25.72 Million CAD

Market Cap Rank

#25304 Global

#985 in Canada

Share Price

CA$9.25

Change (1 day)

+8.82%

52-Week Range

CA$0.13 - CA$14.00

All Time High

CA$14.00